AptarGroup Inc (ATR)

Currency in USD
143.73
+1.23(+0.86%)
Real-time Data·
ATR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
142.50144.57
52 wk Range
110.95148.63
Key Statistics
Prev. Close
142.5
Open
143.94
Day's Range
142.5-144.57
52 wk Range
110.95-148.63
Volume
178.35K
Average Volume (3m)
467.19K
1-Year Change
23.6706%
Book Value / Share
41.12
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ATR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
163.88
Upside
+14.02%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 34 consecutive years

AptarGroup Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

7 Buy
2 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 163.88
(+14.02% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BofA Securities
Buy155.00+7.97%154.00MaintainNov 02, 2026
UBS
Hold135.00-5.96%-New CoverageOct 08, 2026
Wells Fargo
Buy155.00+7.97%-New CoverageOct 08, 2026
Deutsche Bank
Buy150.00+4.49%-New CoverageOct 07, 2026
Wells Fargo
Buy155.00+7.97%145.00MaintainAug 03, 2026

AptarGroup Inc SWOT Analysis


Pharma Powerhouse
AptarGroup's Pharma division shows significant momentum, particularly in biologics, offsetting challenges in other segments and driving overall growth
Financial Fortitude
Strong balance sheet with low debt and consistent performance positions AptarGroup for potential acquisitions and shareholder returns
Market Dynamics
Explore how AptarGroup navigates consumer spending fluctuations and raw material costs while maintaining its competitive edge in packaging solutions
Future Trajectory
Analysts project double-digit earnings growth, with price targets ranging from $168 to $170, driven by innovation in drug delivery systems
Read full SWOT analysis

AptarGroup Inc Earnings Call Summary for Q3/2026

  • Aptar Q3 2026 adjusted EPS of $1.52 beat estimates by 3.4%; revenue of $1.02B topped forecasts by 3.9%, driving shares up 7.9%.
  • Core sales grew 5% with Pharma up 8% ex-emergency medicine; naloxone destocking headwind expected to end in Q4 with no 2027 impact.
  • Q4 guidance: adjusted EPS $1.39-$1.47, implying 17% YoY growth at midpoint; full-year capex expected at $260M-$280M.
  • Margins compressed 120bps YoY due to lower high-margin emergency medicine sales and weak North America Beauty performance requiring extended turnaround.
  • Board approved 4% dividend increase, extending streak to 34 years; company maintains long-term Pharma core sales target of 7%-11%.
Last Updated: 01/11/2026, 11:06
Read Full Transcript

Earnings

Latest Release
Oct 29, 2026
EPS / Forecast
1.52 / 1.47
Revenue / Forecast
1.02B / 981.45M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.17
Dividend Yield
1.40%
Industry Median 3.11%
Annualised payout
2.00
Paid quarterly
5-Years Growth
+5.34%
Growth Streak

ATR Income Statement

Compare ATR to Peers and Sector

Metrics to compare
ATR
Peers
Sector
Relationship
P/E Ratio
34.0x19.1x3.8x
PEG Ratio
−1.012.560.00
Price/Book
3.5x1.8x1.6x
Price / LTM Sales
2.3x1.2x1.1x
Upside (Analyst Target)
14.5%12.1%49.1%
Fair Value Upside
Unlock5.6%5.2%Unlock

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Employees
14000

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
31.33M49.42%4.46B
Other Institutional Investors
30.46M48.05%4.34B
Public Companies & Retail Investors
1.61M2.53%228.92M
Total
63.39M100.00%9.03B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.9.68%6,137,894874,650
State Farm Mutual Automobile Insurance Company7.48%4,744,564676,100

People Also Watch

259.64
NXPI
+4.57%
217.50
LRCX
+8.51%
290.62
WDC
+10.18%
362.24
ETN
+6.00%

FAQ

What Is the AptarGroup (ATR) Stock Price Today?

The AptarGroup stock price today is 143.73 USD.

What Stock Exchange Does AptarGroup Trade On?

AptarGroup is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for AptarGroup?

The stock symbol for AptarGroup is "ATR."

What Is the AptarGroup Market Cap?

As of today, AptarGroup market cap is 9.11B USD.

What Is AptarGroup's Earnings Per Share (TTM)?

The AptarGroup EPS (TTM) is 4.17.

When Is the Next AptarGroup Earnings Date?

AptarGroup will release its next earnings report on Feb 18, 2027.

From a Technical Analysis Perspective, Is ATR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has AptarGroup Stock Split?

AptarGroup has split 2 times.

How Many Employees Does AptarGroup Have?

AptarGroup has 14000 employees.

What is the current trading status of AptarGroup (ATR)?

As of Nov 09, 2026, AptarGroup (ATR) is trading at a price of 143.73 USD, with a previous close of 142.50 USD. The stock has fluctuated within a day range of 142.50 USD to 144.57 USD, while its 52-week range spans from 110.95 USD to 148.63 USD.

What Is AptarGroup (ATR) Price Target According to Analysts?

The average 12-month price target for AptarGroup is 163.88 USD, with a high estimate of 220 USD and a low estimate of 142 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +14.02% Upside potential.

What Is the ATR Premarket Price?

ATR's last pre-market stock price is 143.61 USD. The pre-market share volume is 2,540.00, and the stock has decreased by 1.11, or 0.78%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.